Clinical Trial Update: Observational Study to Investigate the Occurrence of Bleeding in Postmenopausal Women Treated With Estradiol/NETA for 12 Months

View source ↗

Summary

An observational study completed to assess bleeding events in postmenopausal women treated with Estradiol/NETA for 12 months.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause
• Postmenopausal Bleeding

Drugs mentioned

• Estradiol/NETA (estradiol/norethindrone acetate)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Menopause, Postmenopausal Bleeding | Status: COMPLETED